Quarterly report pursuant to Section 13 or 15(d)

RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - CONSOLIDATED STATEMENTS OF STOCKHOLDERS??? DEFICIT (Details)

v3.24.2.u1
RESTATEMENT OF PREVIOUSLY ISSUED FINANCIAL STATEMENTS - CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT (Details) - USD ($)
$ in Thousands
 3 Months Ended 6 Months Ended
Sep. 30, 2022
Sep. 30, 2022
Increase (Decrease) in Stockholders' Equity    
Beginning balance $ (76,499) $ (143,737)
Activity, As Reported $ (10,556) $ 47,341
Ending balance (in shares) 92,158,000 92,158,000
Ending balance $ (82,535) $ (82,535)
Scenario, Adjustment    
Increase (Decrease) in Stockholders' Equity    
Beginning balance 4,520 13,861
Common Stock    
Increase (Decrease) in Stockholders' Equity    
Beginning balance $ 907 $ 605
Beginning balance (in shares) 90,606,000 60,433,000
Stock Issued During Period, Shares, Period Increase (Decrease) 1,552,000 31,725,000
Activity, As Reported $ 15 $ 317
Ending balance (in shares) 92,158,000 92,158,000
Ending balance $ 922 $ 922
Additional Paid-in Capital    
Increase (Decrease) in Stockholders' Equity    
Beginning balance 693,896 624,805
Activity, As Reported 2,671 71,762
Ending balance 696,567 696,567
Accumulated Deficit    
Increase (Decrease) in Stockholders' Equity    
Beginning balance (768,603) (767,724)
Activity, As Reported (11,944) (22,164)
Ending balance (776,027) (776,027)
Accumulated Deficit | Scenario, Adjustment    
Increase (Decrease) in Stockholders' Equity    
Beginning balance 4,520 13,861
Accumulated Other Comprehensive Loss    
Increase (Decrease) in Stockholders' Equity    
Beginning balance (2,699) (1,423)
Activity, As Reported (1,298) (2,574)
Ending balance $ (3,997) $ (3,997)